Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.68 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.68 |
| ▸ | ATM | Q13315 | 1/20 | 0.68 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.68 |
| ▸ | HPGD | P15428 | 4/20 | 0.61 |
| ▸ | GAA | P10253 | 2/20 | 0.61 |
| ▸ | NPC1 | O15118 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 5/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.61 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27734154 | 0.98 | ALDH1A1 (0.66) | ALDH1A1KDM4EL3MBTL1KMT2AATM | |
| SCHEMBL12462566 | 0.98 | ALDH1A1 (0.66) | ALDH1A1KDM4EL3MBTL1KMT2AATM | |
| SCHEMBL24596446 | 0.92 | KDM4E (0.59) | ALDH1A1KDM4EL3MBTL1KMT2AATM | |
| SCHEMBL12111553 | 0.90 | MAPK14 (0.61) | ALDH1A1KDM4EL3MBTL1KMT2AATM | |
| SCHEMBL12595616 | 0.90 | ALDH1A1 (0.79) | ALDH1A1KDM4EL3MBTL1KMT2AATM | |
| SCHEMBL12111667 | 0.90 | MAPK14 (0.61) | ALDH1A1KDM4EL3MBTL1KMT2AATM | |
| SCHEMBL12595573 | 0.90 | ALDH1A1 (0.79) | ALDH1A1KDM4EL3MBTL1KMT2AATM | |
| SCHEMBL12111547 | 0.90 | MAPK14 (0.61) | ALDH1A1KDM4EL3MBTL1KMT2AATM | |
| SCHEMBL24184940 | 0.90 | ALDH1A1 (0.58) | ALDH1A1KDM4EL3MBTL1KMT2AATM | |
| SCHEMBL12111626 | 0.90 | MAPK14 (0.61) | ALDH1A1KDM4EL3MBTL1KMT2AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2113133-B1 | LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE AND QUINOXALINE DERIVATIVE | SEMICONDUCTOR ENERGY LAB (JP) | 2013-04-24 | — | — | EP | claimed |
| US-7875879-B2 | Light-emitting element, light-emitting device, electronic device and quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-01-25 | — | — | US | claimed |
| EP-2113133-A1 | LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE AND QUINOXALINE DERIVATIVE | Semiconductor Energy Laboratory Co, Ltd. (JP) | 2009-11-04 | — | — | EP | claimed |
| US-20080217608-A1 | Light-Emitting Element, Light-Emitting Device, Electronic Device and Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2008-09-11 | — | — | US | claimed |
| WO-2008102713-A1 | LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE AND QUINOXALINE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-08-28 | — | — | WO | claimed |
| JP-6207169-A | — | — | None | — | — | JP | disclosed |
| EP-3931184-A1 | METHOD FOR PRODUCING QUINOXALINES | Technische Universität Wien (AT) | 2022-01-05 | — | — | EP | disclosed |
| US-10633369-B2 | Method of inhibiting DYRK1B | 4 SC AG (DE) | 2020-04-28 | — | — | US | disclosed |
| US-20180201606-A1 | METHOD OF INHIBITING DYRK1B | 4 SC AG (DE) | 2018-07-19 | — | — | US | disclosed |
| US-9951050-B2 | Method of inhibiting DYRK1B | 4 SC AG (DE) | 2018-04-24 | — | — | US | disclosed |
| US-9431574-B2 | Light-emitting device including color filter and black matrix | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-08-30 | — | — | US | disclosed |
| EP-1973386-B1 | LIGHT-EMITTING DEVICE AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LAB (JP) | 2015-11-11 | — | — | EP | disclosed |
| US-20090114926-A1 | Light-emitting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2009-05-07 | — | — | US | disclosed |
| US-20080231177-A1 | Light-Emitting Device and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2008-09-25 | — | — | US | disclosed |
| EP-1973386-A2 | Light-emitting device and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-09-24 | — | — | EP | disclosed |
| US-20080217608-A1 | Light-Emitting Element, Light-Emitting Device, Electronic Device and Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2008-09-11 | — | — | US | disclosed |
| WO-2008102713-A1 | LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE AND QUINOXALINE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-08-28 | — | — | WO | disclosed |
| US-20070141393-A1 | Amino anthracene compounds in OLED devices | EASTMAN KODAK COMPANY | 2007-06-21 | — | — | US | disclosed |
| US-20070141393-A1 | Amino anthracene compounds in OLED devices | EASTMAN KODAK COMPANY | 2007-06-21 | — | — | US | disclosed |
| JP-H06207169-A | ORGANIC ELECTROLUMINESCENCE ELEMENT | IDEMITSU KOSAN CO LTD | 1994-07-26 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10633369-B2 | Method of inhibiting DYRK1B | SMO, GLI1, GRK2 | ALDH1A1 3401/4885KDM4E 996/4885L3MBTL1 3046/4885 |
| US-20180201606-A1 | METHOD OF INHIBITING DYRK1B | SMO, GLI1, GRK2 | ALDH1A1 3401/4885KDM4E 996/4885L3MBTL1 3046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.